Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S.-Canada border could reopen to fully vaccinated travellers July 21: Legault

06/18/2021 | 04:01pm EDT

MONTREAL — The Canadian government is looking at a plan to reopen the United States border to people who are fully vaccinated against COVID-19, Quebec Premier François Legault said Friday.

Legault told reporters at an event in Laval, Que., the reopening could happen when current border restrictions expire on July 21.

“We had a meeting by telephone yesterday evening, the premiers of the provinces with Mr. Trudeau," Legault said. "We’re looking at reopening starting July 21, a scenario is being considered to reopen the borders, but one of the important conditions is to have had two doses, so complete vaccination."

Legault said fully vaccinated Canadians will also be able to travel internationally.

"It’s clear that either you get a double dose of AstraZeneca, or double dose of Moderna, or Pfizer or a mix of double doses, (and) you will have access to international flights,” he said.

Asked about the possibility that Quebecers who have received the Oxford-AstraZeneca vaccine would not be allowed into some events in the United States, such as Broadway shows, Legault said he couldn't control what happens there.

However, he said, Quebec isn't planning to allow the use of proof of vaccination for people to access private activities, like concerts, in the province.

Legault's government had encouraged people 45 and over to receive the AstraZeneca vaccine before it stopped administering first doses of the vaccine due to concerns about rare blood clots and with increased availability of other vaccines.

The province has sent mixed messages in recent days about whether people who have received a first dose of the AstraZeneca vaccine should get a second dose of the same vaccine or opt for one of the others.

On Friday, Legault insisted what's most important is that people who have received a first dose of AstraZeneca get a booster shot — no matter which vaccine they choose.

Legault said public health has advised that for people who have received a first dose of AstraZeneca, getting a dose of either Pfizer-BioNTech or Moderna as a booster may offer slightly more protection, while increasing the risk of temporary side-effects.

Quebec's public health institute said Friday that 79.8 per cent of residents over 12 have received at least one dose of vaccine and 16.8 per cent of residents are now adequately vaccinated.

The province reported 127 new cases of COVID-19 Friday and two more deaths attributed to the novel coronavirus.

Health officials said hospitalizations decreased by three to 175, while 39 people were listed in intensive care, a drop of two.

This report by The Canadian Press was first published June 18, 2021.


This story was produced with the financial assistance of the Facebook and Canadian Press News Fellowship.

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.68% 8236 Delayed Quote.13.22%
MODERNA, INC. -2.19% 328.5 Delayed Quote.221.50%
All news about ASTRAZENECA PLC
10:18aTHE LATEST : Russia OKs test combo Sputnik, AstraZeneca shots
09:42aREGENERON PHARMACEUTICALS : AstraZeneca to Co-Develop, Commercialize New Small M..
08:54aASTRAZENECA : Russia OKs testing combination of Sputnik, AstraZeneca shots
07:10aASTRAZENECA : and Regeneron to research, develop and commercialise new small mol..
04:59aOmega Diagnostics Group Notes Use of Test in Study Tracking COVID-19 Antibody..
02:22aDassault Systemes lifts 2021 outlook on surging software sales
07/26FTSE 100 Delivers Weak Start to Week Despite Strong Mining Sector
07/26ASTRAZENECA : BYDUREON BCise (exenatide extended-release) approved in the US for..
07/26THE LATEST : France digests news of restaurant health passes
07/26ASTRAZENECA : BioNTech aims to develop mRNA-based malaria vaccine
More news
Financials (USD)
Sales 2021 35 405 M - -
Net income 2021 4 669 M - -
Net Debt 2021 10 816 M - -
P/E ratio 2021 23,4x
Yield 2021 3,41%
Capitalization 128 B 177 B -
EV / Sales 2021 3,92x
EV / Sales 2022 3,17x
Nbr of Employees 76 100
Free-Float 96,4%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 82,53 $
Average target price 132,21 $
Spread / Average Target 60,2%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC13.22%177 536
JOHNSON & JOHNSON9.21%452 602
ROCHE HOLDING AG11.50%327 852
PFIZER, INC.13.58%234 040
NOVARTIS AG-0.17%221 954